A detailed history of Two Sigma Securities, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 12,800 shares of BIIB stock, worth $2.22 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,800
Previous 29,200 56.16%
Holding current value
$2.22 Million
Previous $6.3 Million 52.87%
% of portfolio
0.04%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $636,060 - $803,129
3,000 New
3,000 $646,000
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $1.54 Million - $1.78 Million
-5,585 Reduced 80.95%
1,314 $374,000
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $1.48 Million - $1.68 Million
5,755 Added 503.06%
6,899 $1.92 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $322,113 - $391,374
-1,276 Reduced 52.73%
1,144 $316,000
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $471,149 - $649,673
2,420 New
2,420 $646,000
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $1.59 Million - $2 Million
8,184 Added 484.55%
9,873 $2.08 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $208,245 - $267,626
930 Added 122.53%
1,689 $405,000
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $95,479 - $111,859
-393 Reduced 34.11%
759 $212,000
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $684,208 - $1.03 Million
-2,896 Reduced 71.54%
1,152 $282,000
Q2 2020

Sep 10, 2020

SELL
$258.66 - $342.55 $6.13 Million - $8.12 Million
-23,700 Reduced 85.41%
4,048 $1.08 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $6.96 Million - $9.22 Million
26,920 Added 3251.21%
27,748 $7.42 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $1.79 Million - $2.48 Million
-8,152 Reduced 90.78%
828 $246,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $241,358 - $270,706
1,110 Added 14.1%
8,980 $2.09 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $1.13 Million - $1.24 Million
5,140 Added 188.28%
7,870 $1.84 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $428,002 - $669,446
1,975 Added 261.59%
2,730 $645,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $1.75 Million - $2.22 Million
-6,289 Reduced 89.28%
755 $227,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $1.8 Million - $2.35 Million
6,133 Added 673.22%
7,044 $2.49 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $744,490 - $887,276
-2,891 Reduced 76.04%
911 $264,000
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $989,014 - $1.4 Million
3,802 New
3,802 $1.04 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.